These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4904576)

  • 21. [Unrelated match bone marrow transplantation for severe aplastic anemia].
    Urase F; Ishikawa H; Kanbara M; Hazu S; Tsuji K; Ashida T; Tsubaki K; Horiuchi A
    Rinsho Ketsueki; 1993 Dec; 34(12):1584-6. PubMed ID: 8295334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Siemionow M
    Ann Plast Surg; 2006 Mar; 56(3):295-300. PubMed ID: 16508361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning.
    Torjemane L; Ladeb S; Ben Othman T; Abdelkefi A; Lakhal A; Ben Abdeladhim A
    Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of fludarabine as an immunosuppressor for bone marrow transplantation conditioning: preliminary results.
    Terenzi A; Aristei C; Aversa F; Perruccio K; Chionne F; Raymondi C; Latini P; Martelli MF
    Transplant Proc; 1996 Dec; 28(6):3101. PubMed ID: 8962201
    [No Abstract]   [Full Text] [Related]  

  • 26. An in vitro reaction between lymphoid cells and target fibroblastic cells: a possible model for in vivo rejection of haemopoietic allografts.
    Mayhew E; Bennett M
    Immunology; 1971 Jul; 21(1):123-36. PubMed ID: 4934136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma.
    Cavo M; Bandini G; Benni M; Gozzetti A; Ronconi S; Rosti G; Zamagni E; Lemoli RM; Bonini A; Belardinelli A; Motta MR; Rizzi S; Tura S
    Bone Marrow Transplant; 1998 Jul; 22(1):27-32. PubMed ID: 9678792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Symposium on bone marrow transplantation: experimental aspects in canines.
    Thomas ED; Storb R; Epstein RB; Rudolph RH
    Transplant Proc; 1969 Mar; 1(1):31-3. PubMed ID: 5002661
    [No Abstract]   [Full Text] [Related]  

  • 29. A case of cardiac localization of graft-versus-host disease after allogenic bone marrow transplantation.
    Cereda M; Trocino G; Pogliani EM; Schiavina R
    Ital Heart J; 2003 Jan; 4(1):60-3. PubMed ID: 12690924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Increased efficacy of allogenic bone marrow transplantation].
    Fedotenkov AG; Danilova LA; Ignasheva LP
    Biull Eksp Biol Med; 1982 Aug; 94(8):104-8. PubMed ID: 6751429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistant graft failure overcome with allogenic peripheral blood plus bone marrow stem cells.
    Arslan O; Seferoğlu A; Gürman G; Ilhan O; Koç H
    Haematologia (Budap); 1998; 29(1):47-50. PubMed ID: 9704257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
    Zander AR; Berger C; Kröger N; Stockshläder M; Krüger W; Horstmann M; Grimm J; Zeller W; Kabisch H; Erttmann R; Schönrock P; Kuse R; Braumann D; Illiger HJ; Fiedler W; de Witt M; Hossfeld KD; Weh HJ
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2671-5. PubMed ID: 10068272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunohematologic changes in children with hypoplastic anemia after transplantation with allogenic bone marrow].
    Sokolova-Akulova KG; Kalinicheva VI
    Probl Gematol Pereliv Krovi; 1970 Sep; 15(9):21-4. PubMed ID: 4926079
    [No Abstract]   [Full Text] [Related]  

  • 34. Some questions of non-H-2 transplantation tolerance in mice.
    Nĕmec M; Nouza K
    Folia Biol (Praha); 1971; 17(2):86-96. PubMed ID: 4930299
    [No Abstract]   [Full Text] [Related]  

  • 35. Unrelated donor bone marrow transplants for severe aplastic anemia with conditioning using total body irradiation and cyclophosphamide.
    Kim SY; Lee JW; Lim J; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):863-70. PubMed ID: 17580265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing ways of reducing allograft immunogenicity.
    Guttmann RD
    Can Med Assoc J; 1981 Jan; 124(2):143-5. PubMed ID: 7006782
    [No Abstract]   [Full Text] [Related]  

  • 37. Eosinophilia after allogeneic bone marrow transplantation using busulfan and cyclophosphamide conditioning regimen.
    Arslan O; Akan H; Koç H; Beksaç M; Ilhan O; Ozcan M; Yalçín S; Gürman G; Konuk N; Uysal A
    Bone Marrow Transplant; 1996 Jul; 18(1):261. PubMed ID: 8832034
    [No Abstract]   [Full Text] [Related]  

  • 38. Intermediate-dose busulfan and cyclophosphamide as a conditioning regimen for bone marrow transplantation in a case of Fanconi anemia in myelodysplastic transformation.
    Maschan AA; Kryzanovskii OI; Yourlova MI; Skorobogatova EV; Pashanov ED; Potapova YE; Timonova LA; Bogatcheva NY; Samochatova EV; Roumjantzev AG
    Bone Marrow Transplant; 1997 Feb; 19(4):385-7. PubMed ID: 9051250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reduction by azathioprine of inhibition of allogenic bone marrow grafts by prior blood transfusions].
    Mathé G
    Rev Fr Etud Clin Biol; 1966 Dec; 11(10):1026-7. PubMed ID: 5342423
    [No Abstract]   [Full Text] [Related]  

  • 40. Allogeneic canine bone marrow transplantation following cyclophosphamide.
    Storb R; Epstein RB; Rudolph RH; Thomas ED
    Transplantation; 1969 May; 7(5):378-86. PubMed ID: 4890905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.